INTELLIGENT BIO SOLUTIONS INC. financial data

Symbol
INBS on Nasdaq
Location
New York, NY
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 92% % -31%
Quick Ratio 14% % -9.8%
Debt-to-equity 132% % 64%
Return On Equity -282% % -92%
Return On Assets -119% % -47%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,452,553 shares 122%
Common Stock, Shares, Outstanding 9,098,357 shares 108%
Entity Public Float $6,585,683 USD 10%
Common Stock, Value, Issued $90,985 USD 108%
Weighted Average Number of Shares Outstanding, Basic 8,546,934 shares 124%
Weighted Average Number of Shares Outstanding, Diluted 8,546,934 shares 124%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $902,138 USD -0.61%
Revenue from Contract with Customer, Excluding Assessed Tax $3,292,042 USD 3.3%
Cost of Revenue $1,873,693 USD 14%
General and Administrative Expense $9,594,725 USD 9.6%
Operating Income (Loss) $10,918,939 USD -4.2%
Nonoperating Income (Expense) $13,860 USD -52%
Net Income (Loss) Attributable to Parent $10,866,106 USD -4.3%
Earnings Per Share, Basic -1 USD/shares -131%
Earnings Per Share, Diluted -1 USD/shares -131%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,660,105 USD -58%
Accounts Receivable, after Allowance for Credit Loss, Current $717,823 USD 24%
Inventory, Net $628,177 USD -15%
Other Assets, Current $488,182 USD 23%
Assets, Current $4,484,369 USD -31%
Property, Plant and Equipment, Net $271,745 USD -54%
Operating Lease, Right-of-Use Asset $1,808,892 USD 594%
Intangible Assets, Net (Excluding Goodwill) $3,473,303 USD -21%
Assets $10,038,309 USD -14%
Employee-related Liabilities, Current $567,059 USD 19%
Accrued Liabilities, Current $1,189,858 USD 96%
Liabilities, Current $5,062,074 USD -11%
Operating Lease, Liability, Noncurrent $1,449,265 USD 5056%
Liabilities $6,611,380 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $279,228 USD 44%
Retained Earnings (Accumulated Deficit) $65,516,071 USD -20%
Stockholders' Equity Attributable to Parent $3,621,227 USD -41%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3,426,929 USD -42%
Liabilities and Equity $10,038,309 USD -14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,846,825 USD -19%
Net Cash Provided by (Used in) Financing Activities $3,558,165 USD 8282%
Net Cash Provided by (Used in) Investing Activities $70,401 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 9,098,473 shares 108%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $640,196 USD
Deferred Tax Assets, Valuation Allowance $12,698,469 USD 22%
Deferred Tax Assets, Gross $12,713,685 USD 22%
Operating Lease, Liability $84,659 USD -76%
Payments to Acquire Property, Plant, and Equipment $70,401 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $10,649,075 USD -3.2%
Lessee, Operating Lease, Liability, to be Paid $86,910 USD -78%
Property, Plant and Equipment, Gross $339,489 USD -46%
Operating Lease, Liability, Current $362,801 USD 29%
Lessee, Operating Lease, Liability, to be Paid, Year Two $83,509 USD -73%
Lessee, Operating Lease, Liability, to be Paid, Year One $86,910 USD -72%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,251 USD -94%
Preferred Stock, Shares Issued 0 shares
Additional Paid in Capital $69,325,542 USD 13%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $956,193 USD 1.8%
Depreciation, Depletion and Amortization $257,907 USD 6.7%
Deferred Tax Assets, Net of Valuation Allowance $15,216 USD